[PDF][PDF] Deciphering the dilemma: anticoagulation for heart failure with preserved ejection fraction (HFpEF)

FNU Jyotsna, K Mahfooz, H Sohail, S Kumar, M Adeeb… - Cureus, 2023 - cureus.com
Impairment in ventricular relaxation and preserved left ventricular ejection fraction are the
two main features of heart failure with preserved ejection fraction (HFpEF) a difficult clinical …

Oral anticoagulant switching in patients with atrial fibrillation: a scoping review

AR Adelakun, RD Turgeon, MA De Vera, K McGrail… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Oral anticoagulants (OACs) prevent stroke in patients with atrial fibrillation (AF).
Several factors may cause OAC switching. Objectives To examine the phenomenon of OAC …

Oral anticoagulant adherence and switching in patients with atrial fibrillation: a prospective observational study

S Salmasi, A Safari, A Kapanen, A Adelakun… - Research in Social and …, 2022 - Elsevier
Background Adherence to oral anticoagulants (OACs) in patients with atrial fibrillation (AF) is
important in preventing stroke. The dominance of retrospective studies using administrative …

Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study

S Testa, G Palareti, C Legnani, C Dellanoce… - Blood …, 2024 - ashpublications.org
Although effective and safe, treatment with direct oral anticoagulants (DOAC) in atrial
fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of …

Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study

M Wang, M Paterson, L Thabane, D Siegal… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Proton pump inhibitors (PPIs) are widely used for primary and secondary
prevention of upper gastrointestinal bleeding. However, there remains controversy about the …

Innovations in pharmacovigilance studies of medicines in older people

LM Kalisch Ellett, JL Janetzki, R Lim… - British Journal of …, 2024 - Wiley Online Library
Pharmacovigilance is defined by the World Health Organization as “the science and
activities relating to the detection, assessment, understanding and prevention of adverse …

Differences in the location of bleeding with direct oral anticoagulants vs. vitamin K antagonists: A study in the World Health Organization's pharmacovigilance …

JL Montastruc, S Tessier… - British Journal of Clinical …, 2023 - Wiley Online Library
Aims Clinical trials have found differences in bleeding locations between direct oral
anticoagulants (DOAC) and vitamin K antagonists (VKA). The present study was performed …

Development and Application of an Attribute-Based Taxonomy on the Benefits of Oral Anticoagulant Switching in Atrial Fibrillation: A Delphi Study

AR Adelakun, MA De Vera, K McGrail, RD Turgeon… - Advances in …, 2024 - Springer
Introduction Patients with atrial fibrillation (AF) often switch between oral anticoagulants
(OACs). It can be hard to know why a patient has switched outside of a clinical setting …

Time to invest in team-based care

MB Trusler - Canadian Family Physician, 2023 - cfp.ca
February 2023 issue of Canadian Family Physician1 encouraging the adoption of team-
based care as one solution to alleviating the current strain on our family physician resources …

[HTML][HTML] Protocol: Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study

M Wang, M Paterson, L Thabane, D Siegal… - BMJ Open, 2022 - ncbi.nlm.nih.gov
ABSTRACT Introduction Proton pump inhibitors (PPIs) are widely used for primary and
secondary prevention of upper gastrointestinal bleeding. However, there remains …